Search

A new type of drug shows potential in follicular lymphoma

Standard post

… might be effective for people with relapsed or refractory follicular lymphoma. Initial results of the trial … from growing. In this trial, 99 people with relapsed or refractory follicular lymphoma were treated with tazemetostat … has promising efficacy for people with relapsed or refractory follicular lymphoma. Because it is well tolerated, …

EMA recommends new lymphoma treatment options

Standard post

… (DLBCL) that has come back (relapsed) or not responded (refractory) to previous treatment and who are not able to … lymphoma that has come back (relapsed) or not responded (refractory) to previous treatment. Lenalidomide affects the … It is already approved for people with relapsed or refractory mantle cell lymphoma , although it is not …

NICE recommends Axicabtagene ciloleucel for DLBCL

Standard post

… ciloleucel as an option for treating relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or primary … February 2023 … New treatment available for relapsed or refractory diffuse large B-cell lymphoma or primary …

Pembrolizumab for classical Hodgkin lymphoma

Standard post

… Cancer Drugs Fund as an option for treating relapsed or refractory classical Hodgkin lymphoma in adults who have had … Although it is not recommended for treating relapsed or refractory classical Hodgkin lymphoma in adults who have had … recommend pembrolizumab for people with relapsed or refractory Hodgkin lymphoma who have had brentuximab vedotin …